Mossad Sherif B
Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA.
Cleve Clin J Med. 2004 Dec;71(12):918, 920, 923, 927. doi: 10.3949/ccjm.71.12.918.
Faced with a shortage of the inactivated intramuscular influenza vaccine this year, the Centers for Disease Control and Prevention (CDC) has revised its guidelines for immunization and use of antiviral agents. The most rational solution at this time is to direct the supply of scarce vaccine to patients at highest risk of influenza-related complications.
面对今年灭活流感疫苗供应短缺的情况,美国疾病控制与预防中心(CDC)修订了其免疫接种和抗病毒药物使用指南。目前最合理的解决办法是将稀缺疫苗供应给流感相关并发症风险最高的患者。